ROCAGLAMIDE

Overview

Rocaglamide is the first cyclopenta[b]benzofuran derivative extracted from Aglaia elliptifolia in 1982 by King and colleagues. Its IC50 value is ~50 nM for the heat shock reporter. It has antileukemic activity and displays potent insecticidal, antifungal, anti-inflammatory and anticancer activities. It is an immunosuppressant that inhibits activation of NF-kB and NF-AT. It markedly inhibited tumor growth from Huh-7 cells propagated in severe combined immunodeficient mice. It induces apoptosis in various human leukemia cell lines and in acute lymphoblastic leukemia, chronic myeloid leukemia and acute myeloid leukemia cells. It inhibit protein synthesis without affecting DNA or RNA synthesis.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Eukaryotic Initiation Factor (eIF)

Product Information

• Catalog No.: B0084-152543
• CAS No.: 84573-16-0
• Molecular Formula: C29H31NO7
• Molecular Weight: 505.56
• Purity: 95%
• Storage: -20°C Freezer
• Solubility: 10 mM in DMSO

Source

Original product source